Suppr超能文献

拉贝洛尔用药前后去甲肾上腺素和肾上腺素对循环系统的影响。

Circulatory effects of noradrenaline and adrenaline before and after labetalol.

作者信息

Richards D A, Prichard B N, Hernández R

出版信息

Br J Clin Pharmacol. 1979 Apr;7(4):371-8.

Abstract

Two studies were carried out in the same six normal healthy males to compare the circulatory effects of exogenously infused noradrenaline and adrenaline before and after intravenous labetalol. Noradrenaline before and after labetalol produced a similar pattern of circulatory change, namely dose related systolic and diastolic pressor responses accompanied by profound bradycardia and reduced cardiac output. Labetalol competitively antagonized both the systolic and diastolic pressor effects of noradrenaline. Adrenaline at low doses produced a diastolic depressor response accompanied by increases in heart rate and cardiac output. The highest dose also produced smaller increases in heart rate and cardiac output and diastolic pressure increased slightly. All doses provoked increases in systolic pressure. After labetalol all doses of adrenaline provoked a diastolic pressor response which was marked at high doses. The systolic response was attenuated compared with that before labetalol. At all doses, heart rate and cardiac output were reduced. Since in the presence of labetalol both noradrenaline and adrenaline profoundly reduce heart rate and cardiac output whilst increasing blood pressure, it may be unwise to use either of these catecholamines alone if attempts are being made to reverse excessive hypotension from labetalol overdose. Preliminary observations indicate that labetalol does not increase endogenous plasma catecholamines immediately after intravenous injection. Plasma concentrations of noradrenaline and adrenaline after exogenous infusion were increased after labetalol compared with those levels before labetalol. It appears that labetalol inhibits the clearance of catecholamines from the plasma possibly by inhibiting neuronal uptake mechanisms.

摘要

在相同的6名正常健康男性中进行了两项研究,以比较静脉注射拉贝洛尔前后外源性输注去甲肾上腺素和肾上腺素对循环系统的影响。拉贝洛尔用药前后,去甲肾上腺素引起的循环系统变化模式相似,即剂量相关的收缩压和舒张压升高反应,同时伴有显著的心动过缓和心输出量降低。拉贝洛尔竞争性拮抗去甲肾上腺素的收缩压和舒张压升高作用。低剂量肾上腺素引起舒张压降低反应,同时心率和心输出量增加。最高剂量时,心率和心输出量的增加幅度较小,舒张压略有升高。所有剂量均引起收缩压升高。拉贝洛尔用药后,所有剂量的肾上腺素均引起舒张压升高反应,高剂量时更为明显。与拉贝洛尔用药前相比,收缩压反应减弱。所有剂量下,心率和心输出量均降低。由于在拉贝洛尔存在的情况下,去甲肾上腺素和肾上腺素都会显著降低心率和心输出量,同时升高血压,因此如果试图纠正拉贝洛尔过量引起的过度低血压,单独使用这两种儿茶酚胺中的任何一种可能都不明智。初步观察表明,静脉注射拉贝洛尔后,其不会立即增加内源性血浆儿茶酚胺。与拉贝洛尔用药前相比,外源性输注后血浆去甲肾上腺素和肾上腺素浓度在拉贝洛尔用药后升高。似乎拉贝洛尔可能通过抑制神经元摄取机制来抑制血浆中儿茶酚胺的清除。

相似文献

引用本文的文献

6
Pharmacology of combined alpha-beta-blockade. I.α-β联合阻滞的药理学。I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
7
Comparison of labetalol with other anti-hypertensive drugs.拉贝洛尔与其他抗高血压药物的比较。
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):41S-47S. doi: 10.1111/j.1365-2125.1982.tb01888.x.
10
Clinical pharmacology of labetalol.拉贝洛尔的临床药理学
Br J Clin Pharmacol. 1979;8(Suppl 2):89S-93S.

本文引用的文献

4
The release and fate of vaso-active hormones in the circulation.血管活性激素在循环中的释放与转归
Br J Pharmacol. 1969 Feb;35(2):209-42. doi: 10.1111/j.1476-5381.1969.tb07982.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验